Literature DB >> 8912643

1-Sulfooxymethylpyrene is an electrophilic mutagen and ultimate carcinogen of 1-methyl- and 1-hydroxymethylpyrene.

J Horn1, J W Flesher, A F Lehner.   

Abstract

1-Hydroxymethylpyrene and 1-sulfooxymethylpyrene were tested for complete carcinogenic activity by repeated s.c. injection in groups of 12 female Sprague-Dawley rats, respectively. A dose of 0.2 mumol of either 1-sulfooxymethylpyrene or 1-hydroxymethylpyrene was administered every other weekday for 20 doses (i.e., total dose 4 mumol) to each of 12 rats, beginning at 30 days of age. Once a week the rats were weighed then palpated for the appearance of tumors. Tumor-bearing rats were sacrificed 20-50 days after the appearance of first palpable tumor. By 52 weeks, 1-sulfooxymethylpyrene had induced sarcomas at the site of injection in 58% of the rats with an average induction time of 33 weeks. By contrast, 20, 0.2 mumol doses of 1-hydroxymethylpyrene failed to induce tumors at the site of injection in a group of 12 rats. Similarly, neither of the two control groups produced tumors. The present experiment, together with previous data, strongly supports the hypothesis that 1-sulfooxymethylpyrene is either itself an ultimate carcinogen or a direct precursor of an ultimate carcinogen, the highly reactive benzylic carbonium ion, which reacts with DNA to form aralkyl-DNA adducts in a chain of events leading to malignant growth.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912643     DOI: 10.1006/bbrc.1996.1623

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Specific RITA Modification Produces Hyperselective Cytotoxicity While Maintaining In Vivo Antitumor Efficacy.

Authors:  Brian D Peyser; Ann Hermone; Joseph M Salamoun; James C Burnett; Melinda G Hollingshead; Connor F McGrath; Rick Gussio; Peter Wipf
Journal:  Mol Cancer Ther       Date:  2019-07-24       Impact factor: 6.261

2.  Candidate gene association study of esophageal squamous cell carcinoma in a high-risk region in Iran.

Authors:  Mohammad R Akbari; Reza Malekzadeh; Ramin Shakeri; Dariush Nasrollahzadeh; Maryam Foumani; Yulong Sun; Akram Pourshams; Alireza Sadjadi; Elham Jafari; Masoud Sotoudeh; Farin Kamangar; Paolo Boffetta; Sanford M Dawsey; Parviz Ghadirian; Steven A Narod
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

3.  Potent aneugenicity of 1-methylpyrene in human cells dependent on metabolic activation by endogenous enzymes.

Authors:  Zihuan Li; Hang Yu; Meiqi Song; Hansruedi Glatt; Jianjun Liu; Yungang Liu
Journal:  Arch Toxicol       Date:  2020-10-15       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.